Approval · Notice of Compliance 21359 · 2018
JETREA: Notice of Compliance 21359
Issued September 27, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21359
- Date
- September 27, 2018
- Company
- Thrombogenics NvLeuven, Flemish Brabant, Belgium
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
Medicinal ingredients
- OCRIPLASMIN 1.25 MG per ML
- OCRIPLASMIN 2.5 MG per ML